Therefore, these findings confirm the overexpression of WT1 in NSCLC, on the other hand, imply the association of WT1 with the metastasis of NSCLC cells, and suggest the potential of WT1 as a novel prognostic biomarker in NSCLC. The gene discussed is WT1; the disease is non-small cell lung carcinoma.